Correlation Between Consolidated Construction and Krebs Biochemicals

Can any of the company-specific risk be diversified away by investing in both Consolidated Construction and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Consolidated Construction and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Consolidated Construction Consortium and Krebs Biochemicals and, you can compare the effects of market volatilities on Consolidated Construction and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Consolidated Construction with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Consolidated Construction and Krebs Biochemicals.

Diversification Opportunities for Consolidated Construction and Krebs Biochemicals

-0.09

Correlation Coefficient

Consolidated Construction  Krebs Biochemicals

Good diversification

The 3 months correlation between Consolidated and Krebs is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Consolidated Construction Cons and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and Consolidated Construction is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Consolidated Construction Consortium are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of Consolidated Construction i.e., Consolidated Construction and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between Consolidated Construction and Krebs Biochemicals

Assuming the 90 days trading horizon Consolidated Construction Consortium is expected to generate 0.81 times more return on investment than Krebs Biochemicals. However, Consolidated Construction Consortium is 1.23 times less risky than Krebs Biochemicals. It trades about 0.21 of its potential returns per unit of risk. Krebs Biochemicals and is currently generating about 0.13 per unit of risk. If you would invest  1,201  in Consolidated Construction Consortium on September 4, 2024 and sell it today you would earn a total of  699.00  from holding Consolidated Construction Consortium or generate 58.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

Consolidated Construction Cons  vs.  Krebs Biochemicals and

Consolidated Construction

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Consolidated Construction Consortium are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Consolidated Construction unveiled solid returns over the last few months and may actually be approaching a breakup point.

Krebs Biochemicals and

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Consolidated Construction and Krebs Biochemicals

The main advantage of trading using opposite Consolidated Construction and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Consolidated Construction position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.

The idea behind Consolidated Construction Consortium and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.